4//SEC Filing
Sassi Nir 4
Accession 0001213900-19-018237
CIK 0001638381other
Filed
Sep 15, 8:00 PM ET
Accepted
Sep 16, 9:32 PM ET
Size
5.3 KB
Accession
0001213900-19-018237
Insider Transaction Report
Form 4
Sassi Nir
Chief Financial Officer
Transactions
- Award
Stock Option (right to buy)
2019-09-13+200,000→ 200,000 totalExercise: $0.90Exp: 2026-09-13→ Ordinary Shares (200,000 underlying)
Footnotes (1)
- [F1]The stock option vests and becomes exercisable as to one-third of the total shares on September 13, 2020 and thereafter the remaining shares vest and become exercisable in equal quarterly installments through September 13, 2022.
Documents
Issuer
Intec Pharma Ltd.
CIK 0001638381
Entity typeother
Related Parties
1- filerCIK 0001760673
Filing Metadata
- Form type
- 4
- Filed
- Sep 15, 8:00 PM ET
- Accepted
- Sep 16, 9:32 PM ET
- Size
- 5.3 KB